Joe Bonaccorso is CCO at Verrica Pharmaceuticals Inc. (VRCA). They have made 5 open-market trades across 1 company since 2018, most recently 2024-08-27.
CIK 0001741973
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15K since 2018, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRCA | 73,114 | $258K |
Shares reported on the most recent Form 4, priced at the 2024-08-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRCA | SELL | 2024-08-26 | 2024-08-28 | $2.63 | $154K | -16.3% | -27.5% | -52.4% |
| VRCA | SELL | 2024-07-22 | 2024-07-23 | $7.06 | $360K | -20.5% | -61.8% | -78.5% |
| VRCA | SELL | 2023-11-14 | 2023-11-16 | $2.94 | $160K | +12.7% | +60.2% | +52.2% |
| VRCA | SELL | 2023-07-24 | 2023-07-25 | $4.83 | $370K | -2.4% | -19.0% | -34.2% |
| VRCA | BUY | 2018-06-19 | 2018-08-15 | $15.00 | $15K | +6.3% | +0.6% | -6.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.